Viewing Study NCT01885260


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-03-01 @ 6:02 AM
Study NCT ID: NCT01885260
Status: COMPLETED
Last Update Posted: 2016-07-04
First Post: 2013-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes
Sponsor: Ionis Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module